Real-life treatment outcomes of ravulizumab in PNH

Trial Identifier: D9289R00001
Sponsor: AstraZeneca
Start Date: February 2025
Primary Completion Date: August 2028
Study Completion Date: August 2028

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Poland Bialystok, Poland
Poland Brzozow, Poland
Poland Bydgoszcz, Poland
Poland Gdansk, Poland
Poland Krakow, Poland
Poland Lodz, Poland
Poland Lublin, Poland
Poland Opole, Poland
Poland Szczecin, Poland
Poland Walbrzych, Poland
Poland Warsaw, Poland
Poland Wroclaw, Poland